Literature DB >> 10353256

Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells.

K Ikeda1, K Kajiwara, E Tanabe, S Tokumaru, E Kishida, Y Masuzawa, S Kojo.   

Abstract

Effects of three kinds of antagonists against reactive oxygen species were evaluated at the same time in chemically induced apoptosis of human leukemic HL-60 cells. Apoptosis of HL-60 cells induced by actinomycin D, H7, 1-beta-D-arabinofuranosylcytosine, and daunorubicin was inhibited significantly by radical scavengers (vitamin E, N-acetyl-L-cysteine, and mercaptoethanol), catalase, and a spin trap, N-t-butyl-alpha-phenylnitrone. These results suggest that hydrogen peroxide and hydroxyl radical are common mediators of apoptosis caused by these chemicals with apparently different functional mechanisms. The consumption of vitamin E to inhibit apoptosis induced by actinomycin D was undetectable, suggesting that the generation of reactive oxygen species during apoptosis was not very extensive. Radicals were suggested to be a mediator of apoptosis of HL-60 cells induced by cisplatin based on the observations that the above inhibitors, except catalase, effectively inhibited apoptosis by the drug.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353256     DOI: 10.1016/s0006-2952(99)00055-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  DNA-SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma.

Authors:  Santanu Bhattacharya; Xun Gong; Enfeng Wang; Shamit K Dutta; Joseph R Caplette; Manki Son; Freddy T Nguyen; Michael S Strano; Debabrata Mukhopadhyay
Journal:  Cancer Res       Date:  2019-07-10       Impact factor: 12.701

2.  c-Myc modulation: a key role in melanoma drug response.

Authors:  Annalisa Fico; Daniela Alfano; Anna Valentino; Valeria Vasta; Ernesta Cavalcanti; Salvatore Travali; Eduardo J Patriarca; Emilia Caputo
Journal:  Cancer Biol Ther       Date:  2015-04-02       Impact factor: 4.742

Review 3.  Protein kinase C targeting in antineoplastic treatment strategies.

Authors:  W D Jarvis; S Grant
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

4.  A macrocyclic zinc(II) fluorophore as a detector of apoptosis.

Authors:  Eiichi Kimura; Shin Aoki; Emiko Kikuta; Tohru Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

5.  Differential effects of vitamin E and three hydrophilic antioxidants on the actinomycin D-induced and colcemid-accelerated apoptosis in human leukemia CMK-7 cell line.

Authors:  Mie Tsuruga; Yong Dang; Yoshihito Shiono; Syuichi Oka; Yoshimitsu Yamazaki
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

Review 6.  A new view of carcinogenesis and an alternative approach to cancer therapy.

Authors:  Miguel López-Lázaro
Journal:  Mol Med       Date:  2009-12-28       Impact factor: 6.354

7.  Cortical neurons transgenic for human Abeta40 or Abeta42 have similar vulnerability to apoptosis despite their different amyloidogenic properties.

Authors:  Najeeb A Shiwany; Jun Xie; Qing Guo
Journal:  Int J Clin Exp Pathol       Date:  2008-11-26

8.  A simultaneous release of SOD1 with cytochrome c regulates mitochondria-dependent apoptosis.

Authors:  Quan Li; Eisuke F Sato; Xiaoping Zhu; Masayasu Inoue
Journal:  Mol Cell Biochem       Date:  2008-11-11       Impact factor: 3.396

9.  Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut.

Authors:  S P Bach; S E Williamson; S T O'Dwyer; C S Potten; A J M Watson
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

10.  Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer.

Authors:  A Bottini; A Berruti; M P Brizzi; A Bersiga; D Generali; G Allevi; S Aguggini; G Bolsi; S Bonardi; G Bertoli; P Alquati; L Dogliotti
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.